NIHR Maudsley BRC Blog

Our latest news & events

Telling our stories of research through a new microsite

This week we are launching a new microsite - Stories of Research - to showcase the impactful work of our NIHR Maudsley BRC. Over the years, our Biomedical Research Centre has brought together scientists, clinicians, mental health professionals, industry, government, service users and carers to produce valuable research that is making difference to the lives of those affected by mental health conditions.

 

By NIHR Maudsley BRC at 7 Mar 2022

New research suggests a causal link between blood group and severe COVID-19

A new study has analysed over 3000 proteins to identify which are causally linked to the development of severe COVID-19. This is the first study to assess such a large number of proteins for their connection to COVID-19. The findings provide insight into potential new targets for approaches to treat and prevent severe COVID-19.

 

By NIHR Maudsley BRC at 3 Mar 2022

Young women with epilepsy at greater risk of stress induced seizures and drug resistance

New research part-funded by the NIHR Maudsley Biomedical Research Centre has established sex-specific factors that are linked to prognosis and drug resistance in juvenile myoclonic epilepsy (JME).

 

By NIHR Maudsley BRC at 23 Feb 2022

Lessons learnt as addictions researchers during a global pandemic

Dr Basak Tas, Dr Amir Englund and Dr Stephen Sharman are all researchers in the Centre for Addiction Research, King’s College London. Recently they published an article in the journal Addiction where they discussed the challenges and advantages that the pandemic has brought through the shift to more remote research. In this blog they summarise their conclusions.

By NIHR Maudsley BRC at 21 Feb 2022

Novavax COVID-19 jab trialled at King’s CRF approved by UK drugs agency

UK drugs regulator, the Medicine and Healthcare products Regulatory Agency (MHRA) has approved Novavax's Nuvaxovid vaccine, which was trialled at the King's CRF, for use in the UK.

By NIHR Wellcome King's Clinical Research Facility at 16 Feb 2022